Drugs / STI-8591
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05947344 | Dec 2023 → Dec 2025 overdue | acute myeloid leukemia | Zhejiang ACEA Pharmaceutical Co. Ltd. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | STI-8591 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05947344 ↗ |